October 21, 2019

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Key Points

Key points are not available for this paper at this time.

Abstract

These data underline the fundamental importance of macrophage-derived CXCR3 ligands for the therapeutic efficacy of ICB and highlight the potential of manipulating this axis to enhance patient responses.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Imran G. House

Peter Savas

Junyun Lai

Journals

Clinical Cancer Research

Actions

Institutions

The University of Melbourne

Monash University

Peter MacCallum Cancer Centre

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study